Medicamen Biotech Limited — Others, 22-03-2025: Trading Plan under PIT

Medicamen Biotech Limited has announced a board meeting regarding the purchase of 21,000 equity shares from the open market by Shivalik Rasayan Limited. This disclosure aligns with compliance requirements under insider trading regulations. The share acquisition could signify confidence in Medicamen's future, potentially influencing investor sentiment positively. Increased insider buying often reflects a belief in the company's prospects, suggesting that investors may view this as a supportive signal for the company's financial health and operational integrity.